Skip to content

Seroma Prevention After Body Contouring Procedures

Prevention of Seroma Formation After Body Contouring Procedures

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03190876
Enrollment
100
Registered
2017-06-19
Start date
2017-03-01
Completion date
2022-03-01
Last updated
2019-05-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Abdominoplasty, Complication of Surgical Procedure, Seroma

Keywords

Drain usage

Brief summary

With a prevalence of up to 25%, seroma formation is among the most common complications of body contouring procedures such as abdominoplasty. Small amounts of fluid are reabsorbed by the body spontaneously, however, larger seroma volumes need to be evacuated via puncture aspiration to prevent wound healing disturbances and infection, leading to major patient discomfort and a prolonged hospital stay. There is increasing controversy regarding the efficacy of surgical drains in seroma prevention. This study compares the incidence rate of seroma in three study arms with different usage of drains.

Interventions

PROCEDUREVariable drain usage

Influence of drain usage on seroma formation rate

Sponsors

University of Regensburg
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
Yes

Inclusion criteria

* All full-aged patients requiring body contouring procedures in our department who provide oral and written informed consent indicating that they agree to participate in the study

Exclusion criteria

* Minors or patients with a designated health care proxy, revision surgeries, morbid obesity

Design outcomes

Primary

MeasureTime frameDescription
Rate of seroma formationWeekly follow-up until postoperative week 6.As primary outcome this study measures the rate of seroma requiring evacuation via puncture aspiration (fluid retention \> 20 cc) in each group.

Countries

Germany

Contacts

Primary ContactAlexandra Anker, Dr. med. univ.
aanker@caritasstjosef.de0049 941 782 3110

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026